# FDA clears Medtronic Hugo for general surgery procedures

*On 17 November 2026 Medtronic announced FDA clearance of the Hugo robotic system for upper and lower abdominal general surgery.*

Published: 2026-11-18 · Segment: In Healthcare

![The four components of Medtronic's Hugo robotic-assisted surgery system on a white background: a remote surgeon-consultation cart, the surgeon console with a screen and hand controllers, the central tower with a monitor and equipment stack, and a robotic arm cart.](https://roboticsdaily.robotshop.com/_astro/medtronic-hugo-fda-general-surgery-2026-11.BRWSk-_b_Z2gI8vx.jpeg)

Image: Medtronic / PR Newswire · press-kit

Medtronic announced on 17 November 2026 that the US Food and Drug Administration cleared the Hugo robotic-assisted surgery system for general surgery procedures. The clearance covers upper abdominal procedures, including cholecystectomy, Roux-en-Y gastric bypass, ventral hernia repair and small bowel resection, and lower abdominal procedures such as inguinal hernia repair and appendectomy.

Medtronic says these procedures represent about 3.5 million US surgeries a year, more than half of US soft-tissue procedures. The company expects Hugo to pass 50,000 procedures by the end of its fiscal year, and says the LigaSure RAS Maryland vessel-sealing instrument is now available for use with the system.

The clearance is an expanded 510(k) and the release does not give a US launch schedule or pricing. The procedure volumes and the 50,000 projection are Medtronic figures.

## Sources

- [Medtronic (PR Newswire, via Yahoo Finance)](https://finance.yahoo.com/healthcare/articles/medtronic-announces-fda-clearance-general-110000749.html) (primary source)

Read this capsule on Robotics Daily: https://roboticsdaily.robotshop.com/capsules/medtronic-hugo-fda-general-surgery-2026-11/
